Logo image of BPYPO

BROOKFIELD PROPERTY PART - BPY 6 3/8 PERP (BPYPO) Stock Fundamental Analysis

NASDAQ:BPYPO - Nasdaq - BMG162491564 - Currency: USD

14.8  -0.13 (-0.87%)

Fundamental Rating

2

Taking everything into account, BPYPO scores 2 out of 10 in our fundamental rating. BPYPO was compared to 85 industry peers in the Chemicals industry. BPYPO may be in some trouble as it scores bad on both profitability and health. BPYPO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BPYPO has reported negative net income.
BPYPO had a positive operating cash flow in the past year.
In the past 5 years BPYPO reported 4 times negative net income.
BPYPO had a positive operating cash flow in 4 of the past 5 years.
BPYPO Yearly Net Income VS EBIT VS OCF VS FCFBPYPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B

1.2 Ratios

Looking at the Return On Assets, with a value of -0.46%, BPYPO is doing worse than 61.18% of the companies in the same industry.
BPYPO has a Return On Equity of -5.22%. This is in the lower half of the industry: BPYPO underperforms 64.71% of its industry peers.
BPYPO has a worse Return On Invested Capital (3.28%) than 63.53% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BPYPO is below the industry average of 6.84%.
The 3 year average ROIC (3.23%) for BPYPO is below the current ROIC(3.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.46%
ROE -5.22%
ROIC 3.28%
ROA(3y)-0.29%
ROA(5y)-0.3%
ROE(3y)-3.87%
ROE(5y)-3.15%
ROIC(3y)3.23%
ROIC(5y)3.15%
BPYPO Yearly ROA, ROE, ROICBPYPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

BPYPO's Operating Margin of 38.35% is amongst the best of the industry. BPYPO outperforms 97.65% of its industry peers.
BPYPO's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 54.78%, BPYPO belongs to the best of the industry, outperforming 95.29% of the companies in the same industry.
BPYPO's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 38.35%
PM (TTM) N/A
GM 54.78%
OM growth 3Y-4.33%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.18%
GM growth 5Y-4.52%
BPYPO Yearly Profit, Operating, Gross MarginsBPYPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

BPYPO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BPYPO has more shares outstanding
Compared to 5 years ago, BPYPO has less shares outstanding
BPYPO has a better debt/assets ratio than last year.
BPYPO Yearly Shares OutstandingBPYPO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BPYPO Yearly Total Debt VS Total AssetsBPYPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

A Debt/Equity ratio of 4.17 is on the high side and indicates that BPYPO has dependencies on debt financing.
With a Debt to Equity ratio value of 4.17, BPYPO is not doing good in the industry: 90.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.17
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.59
WACC5.52%
BPYPO Yearly LT Debt VS Equity VS FCFBPYPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B

2.3 Liquidity

A Current Ratio of 0.21 indicates that BPYPO may have some problems paying its short term obligations.
The Current ratio of BPYPO (0.21) is worse than 97.65% of its industry peers.
BPYPO has a Quick Ratio of 0.21. This is a bad value and indicates that BPYPO is not financially healthy enough and could expect problems in meeting its short term obligations.
BPYPO has a worse Quick ratio (0.20) than 97.65% of its industry peers.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.2
BPYPO Yearly Current Assets VS Current LiabilitesBPYPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.18% over the past year.
The Revenue for BPYPO has decreased by -10.70% in the past year. This is quite bad
The Revenue has been growing slightly by 2.12% on average over the past years.
EPS 1Y (TTM)16.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.94%
Revenue 1Y (TTM)-10.7%
Revenue growth 3Y8.67%
Revenue growth 5Y2.12%
Sales Q2Q%-24.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BPYPO Yearly Revenue VS EstimatesBPYPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
BPYPO Yearly EPS VS EstimatesBPYPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 0 1 -1 2 -2

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BPYPO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BPYPO Price Earnings VS Forward Price EarningsBPYPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BPYPO.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.16
BPYPO Per share dataBPYPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 -500 1K -1K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

BPYPO has a Yearly Dividend Yield of 11.05%, which is a nice return.
Compared to an average industry Dividend Yield of 3.75, BPYPO pays a better dividend. On top of this BPYPO pays more dividend than 97.65% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, BPYPO pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.05%

5.2 History

The dividend of BPYPO has a limited annual growth rate of 1.63%.
BPYPO has been paying a dividend for over 5 years, so it has already some track record.
BPYPO has decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.63%
Div Incr Years0
Div Non Decr Years2
BPYPO Yearly Dividends per shareBPYPO Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

BPYPO has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-110.2%
EPS Next 2YN/A
EPS Next 3YN/A
BPYPO Yearly Income VS Free CF VS DividendBPYPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B

BROOKFIELD PROPERTY PART - BPY 6 3/8 PERP

NASDAQ:BPYPO (6/20/2025, 8:18:44 PM)

14.8

-0.13 (-0.87%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners19.43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap108.93M
Analysts46.67
Price TargetN/A
Short Float %0.29%
Short Ratio1.89
Dividend
Industry RankSector Rank
Dividend Yield 11.05%
Yearly Dividend1.48
Dividend Growth(5Y)1.63%
DP-110.2%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-02 2025-06-02 (0.3984375)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.24
P/B 0.01
P/tB 0.02
EV/EBITDA 14.16
EPS(TTM)-1.29
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1316.85
FCFYN/A
OCF(TTM)62.64
OCFY423.22%
SpS1160.33
BVpS1174.18
TBVpS918.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.46%
ROE -5.22%
ROCE 4.16%
ROIC 3.28%
ROICexc 3.36%
ROICexgc 3.45%
OM 38.35%
PM (TTM) N/A
GM 54.78%
FCFM N/A
ROA(3y)-0.29%
ROA(5y)-0.3%
ROE(3y)-3.87%
ROE(5y)-3.15%
ROIC(3y)3.23%
ROIC(5y)3.15%
ROICexc(3y)3.36%
ROICexc(5y)3.27%
ROICexgc(3y)3.45%
ROICexgc(5y)3.36%
ROCE(3y)4.09%
ROCE(5y)3.99%
ROICexcg growth 3Y-3.47%
ROICexcg growth 5Y2.52%
ROICexc growth 3Y-3.3%
ROICexc growth 5Y2.51%
OM growth 3Y-4.33%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.18%
GM growth 5Y-4.52%
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 4.17
Debt/FCF N/A
Debt/EBITDA 9.91
Cap/Depr 2781.64%
Cap/Sales 118.89%
Interest Coverage 0.8
Cash Conversion 12.66%
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.2
Altman-Z N/A
F-Score4
WACC5.52%
ROIC/WACC0.59
Cap/Depr(3y)1344.37%
Cap/Depr(5y)1108.74%
Cap/Sales(3y)60.6%
Cap/Sales(5y)50.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.94%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.7%
Revenue growth 3Y8.67%
Revenue growth 5Y2.12%
Sales Q2Q%-24.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.57%
EBIT growth 3Y3.96%
EBIT growth 5Y-1.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-146.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y136.68%
OCF growth 3Y17.7%
OCF growth 5Y9.63%